Probably the greatest contribution to the field of chemotherapy was Domagk's introduction of prontosil (chrysoidin) in 1935. Trefouel et al. (1935) (Lawrence, 1944 (Lawrence, , 1945 to conduct an extensive study on the in vitro activities of p-aminoalkylbenzenesulfonamides against a variety of microorganisms. It also stimulated an interest in the search for other possible sulfonamides which are unaffected by p-aminobenzoic acid. Compounds of this type were found when a group of sulfanilylanilides was investigated. The main representative of this group is sulfanilyl-3,5-dibromoanilide. A discussion of p-aminobenzoic acid relationships to the latter will be presented in another section of this report.
Probably the greatest contribution to the field of chemotherapy was Domagk's introduction of prontosil (chrysoidin) in 1935. Trefouel et al. (1935) soon theorized that in the tissues prontosil was broken down at the azo linkage to triaminobenzene and p-aminobenzenesulfonamide, and that this latter group was the active part of the prontosil molecule. The introduction of prontosil and its active principle, sulfanilamide, opened the way for successful treatment of streptococcal, gonococcal, and meningococcal infections. Inasmuch as pneumococcus infections did not respond to sulfanilamide therapy, it remained for Whitby (1938) to introduce sulfapyridine, a sulfonamide effective in the treatment of pneumococcus infections as well as those previously mentioned. With this impetus given to sulfonamide research, several new and important compounds were soon introduced: sulfathiazole by Fosbinder and Walter (1939) , sulfadiazine by Roblin et at. (1940) , and sulfaguanidine by Marshall e al. (1940) . Up to this period none of the sulfonamide compounds were found to have any appreciable effect against certain other groups of organisms, notably the anaerobic clostridia commonly associated with war-wound infections. Miller et al. (1940) synthesized p-aminomethylbenzenesulfonamide (sulfamylon1) which was subsequently found by Klarer (1941) to be highly effective against certain anaerobic bacteria. Moreover, Schreus (1942) found that paminomethylbenzenesulfonamide was unaffected by p-aminobenzoic acid, an attribute not associated with the common sulfonamides described heretofore. These observations led one of us (Lawrence, 1944 (Lawrence, , 1945 to conduct an extensive study on the in vitro activities of p-aminoalkylbenzenesulfonamides against a variety of microorganisms. It also stimulated an interest in the search for other possible sulfonamides which are unaffected by p-aminobenzoic acid.
Compounds of this type were found when a group of sulfanilylanilides was investigated. The main representative of this group is sulfanilyl-3,5-dibromoanilide. A discussion of p-aminobenzoic acid relationships to the latter will be presented in another section of this report.
To our knowledge, there is no reference in the literature to the antibacterial effects of di-halogen-substituted sulfanilylanilides. Suter and Weston (1940) , however, described the preparation of a mono-halogenated sulfanilylanilide, sulfanilyl-4-fluoroanilide, and noted that it showed a slight effect against streptococcal infections in mice. Marchant et al. (1942) described a series of 38 N'-substituted sulfanilamides, among which was sulfanilyl-4-bromoanilide.
G. R. GOETCHIUS AND C. A. LAWRENCE They found that this compound did not possess antibacterial activity against any of their test organisms. In both the foregoing instances only a single halogen atom is attached to the anilide portion of the molecule. Long and Burger (1941) synthesized a series of iodinated aromatic compounds and included in their group sulfanilyl-2,4-diiodoanilide. However, their studies did not include data on antibacterial activity.
When preliminary tests showed that the antibacterial activity of sulfanilyl-3, 5-dibromoanilide was unaffected by p-aminobenzoic acid, studies were made to determine the in vitro effects of the compound upon a wide variety of bacteria. Assuming that the activity of the compounid was not due to the NH2 group in the para-position, but rather to the other components of the molecule, an analogous compound was prepared and tested in which the amino group was lacking, i.e., benzenesulfon-3, 5-dibromoanilide.2 Another compound was studied in which the bromine atoms were replaced by two chlorine atoms, or sulfanilyl-3, 5-dichloroanilide. Due to the relative insolubility of the compounds mentioned, their sodium salts were prepared and were compared with the parent anilides for activity. In addition, derivatives were tested in which the two halogen atoms were in various positions on the ring. Several mono-halogenated compounds, two acetyl derivatives, and the simple 3,5-dibromoaniline were added to the series. Ethanesulfon-3,5-dibromoanilide and the p-aminomethylbenzenesulfonamide analogue of the "type-compound," aminomethylbenzenesulfon-3,5-dibromoanilide, completed the group. A list of the compounds together with their molecular weights is given in table 1. In figure 1 
METHODS
With the exception of the studies in which the gonococcus was used, the general method of testing the compounds was as follows: An initial dilution of 1:1,000 of each compound was prepared in a broth medium. Compounds which were relatively insoluble in water were first dissolved in a few milliliters of alcohol or, in some instances, in a molar solution of sodium carbonate preparatory to making the initial broth dilution (table 1) . From the latter, serial dilutions were prepared in broth up to and including 1:512,000. The tubes were auto-claved at 10 pounds for 10 minutes. In the pneumococcus, meningococcus, and streptococcus tests normal horse serum was added to the medium to give a final concentration of 0.1 per cent. The inoculum added to each tube was one 4-mm loopful of a 24-hour broth culture of the test organism. The organisms used and the media in which they were tested are as follows: After inoculation all tubes were incubated at 37 C and examined for visible growth at intervals of 24, 48, and 72 hours. Lack of growth after 24 hours' incubation was considered evidence of bacteriostasis. Tubes which failed to show growth at the end of 72 hours were tested for bactericidal activity by transferring 3 loopfuls of the drug organism broth mixture to a broth medium lacking the drug. Failure of growth to appear in the subculture tube was taken as evidence of bactericidal action on the part of the drug in the original medication tube. The results of tests against the gram-positive cocci, the gram-negative and gram-positive bacilli, and the gram-negative cocci are given in tables 2, 3, and 4, respectively.
The test procedure was modified somewhat in the studies on gonococci. Dilutions up to and including 1:150,000 of the compounds were prepared in a medium of the following composition: After autoclaving, each tube was inoculated with a loopful of a saline suspension of gonococcal cells. The suspension was prepared by washing the growth from a 24-hour glucose starch agar slant (Difco) with 5 ml of physiological saline solution. The inoculated tubes were incubated at a temperature of 37 C. Subcultures were made from these tubes to fresh glucose starch agar after the organisms had been exposed for 24 and 48 hours to the test compounds. The subculture tubes were incubated at 37 C for 72 hours, and the amount of growth recorded. Complete absence of growth on the slants was taken as evidence of a bactericidal effect of the drug upon the organisms in the original mixture. The results of the tests against gonococci are part of table 4.
RESULTS
As indicated in table 2, the gram-positive cocci are affected to the greatest extent by sulfanilyl-3 ,5-dibromoanilide, sulfanilyl-3 ,5-dichloroanilide, and their sodium salts (compounds 1, 2, 8, and 9) . The removal of the amino group (compounds 3 and 10) results in a slight loss of activity. It would appear, therefore, that sulfanilylanilides or benzenesulfonanilides having two halogen (table 3) , it may be noted that the compounds in which the bromine or chlorine atoms are in the 3 or 3,4 or 3,5 positions on the anilide portions of the molecules exhibit the greatest antibacterial effect (compounds 1, 2, 3, 8, 9, 10, 12, 14, and 16). With but few exceptions, the compounds have little, if any, effect against the gram-negative enteric bacilli. The only consistent results which may be considered significant are obtained with aminomethylbenzenesulfon-3,5-dibromoanilide, ethanesulfon-3,5-dibromoanilide, and the simple 3,5-dibromoanilines (compounds 4, 5, 6, and 7).
In general the anilides are effective against the meningococci (table 4) . Most of them are superior to sulfanilamide and p-aminomethylbenzene sulfonamide but less active than sulfathiazole. It should be noted that sulfanilyl-3, 5-dibromoanilide (compound 1) compares in activity with sulfathiazole. Throughout all these tests the single halogen compound, benzenesulfon-2-chloroanilide (compound 11) and the N4 acetyl derivatives of either sulfanilyl-3, 5-dichloro-or sulfanilyl-3, 5-dibromoanilide (compounds 17 and 18) show practically no antibacterial activity, regardless of the organisms used. Aside from these three compounds, the remainder have a definite inhibitory action against one organism or another. There is, furthermore, a suggestion of specificity of one type of compound for a certain group of organisms. <1  <1  <1  <1   12  8  4  8  8  <1  <1  1  1  8  8  13  8  8  8  8  <1  <1  1  <1  8  8  14  16  16  32  32  <1  <1  <1  <1  4  <1  15  <1  <1  <1  <1  <1  <1  <1  <1  <1  <1  16  16  16  16  16  <1  <1  <1  <1  4  <1  17  <1  <1  <1  <1  <1  <1  <1  <1  <1  <1  18  <1  <1  <1  <1  <1  <1  <1  <1  <1  <1   See legend under table 2. * Identical results were obtained with Salmonella paratyphi.
Of particular interest are the results obtained with the various strains of gonococci. Whereas strains Led, 91, and 66 are relatively sensitive to the sulfonamides, strain Spr appears to be of the "sulfonamide-resistant" type. Most impressive, therefore, is the activity shown against the latter strain by the majority of the anilides. Compounds 11, 15, 17, and 18 were the only derivatives ineffective against strain Spr.
Tests with p-Aminobenzoic Acid
A compound representative of the sulfanilyl-dibromoanilides (compound 8) and one representative of the benzenesulfon-dibromoanilides (compound 10) were each dissolved in distilled water to give molar concentrations of 10-2, 10-3, and 10-4. Dilutions of p-aminobenzoic acid were prepared in a similar manner. All solutions were autoclaved at 10 pounds for 10 minutes. Each To each tube was added 0.1 ml of a 1:500 dilution of a 24-hour veal glucose broth culture of Streptococcus pyogenes (C-203) . The final concentrations of p-aminobenzoic acid and the test compounds thus became 10-3, 10-4, and 10-5 molar. The tubes were incubated at 37 C and examined for growth after 24, 48, and 72 hours. The data (table 5) show that p-aminobenzoic acid, in the concentrations tested, did not antagonize the bacteriostatic activity of either test compound.
DISCUSSION
While studying the mechanism of action of sulfanilamide, Woods (1940) noted that small amounts of p-aminobenzoic acid would block completely the the antibacterial effects of the compound. On the basis of this observation, Woods and Fildes (1940) advanced a theory to explain the mechanism of action of sulfanilamide upon bacteria. These investigators assumed that p-aminobenzoic acid is an essential growth factor for the organism and noted that relatively minute amounts of the acid would antagonize the antibacterial effects of sulfanilamide. On the basis of their findings, they explained the interference of sulfonamide action as a competitive inhibition due to the structural relationship existing between the two compounds. Until recently, all sulfonamides containing a free NH2 group were found to be antagonized by the presence of p-aminobenzoic acid. The fact that p-aminomethylbenzenesulfonamide, and later the benzenesulfonanilides, were unaffected by p-aminobenzoic acid was anticipated in part, inasmuch as in the former compound the para-amino group is separated from the benzene ring by a methyl radical, and in the latter compound the amino group is entirely lacking. Schreus (1942) postulated that whereas p-aminobenzoic acid is not concerned with the action of p-aminomethylbenzenesulfonamide, one of its analogues, namely, p-aminomethylbenzoic acid, is the metabolite which is in competition with p-aminomethylbenzenesulfonamide for the growth of the organisms. One of us (Lawrence, 1944 (Lawrence, , 1945 , however, has brought forth evidence of the inability of p-aminomethylbenzoic acid to interfere with the antibacterial effects of p-aminomethylbenzenesulfonamide, thus invalidating the theory of Schreus and proving this relationship to be incompatible with the Woods-Fildes theory.
Contrary to expectation, the sulfanilylanilides studied in the present investigations, although containing a free NH2 group in the para-position, were un-affected by the presence of p-aminobenzoic acid. The results obtained both with the sulfanilylanilides and with p-aminomethylbenzenesulfonamide, therefore, are in contradiction to the tenets of the Woods-Fildes theory.
Probably one of the best approaches to the solution of the problem of the mechanism of sulfonamide action is a study of drug antagonists. The antagonism displayed by p-aminobenzoic acid toward the commonly known sulfonamides (sulfanilamide, sulfathiazole, etc.) suggests that antibacterial activity is produced by interference with some metabolic function of the bacterial cell. We have tested a large number of vitamins and vitamin derivatives, amino acids, and carbohydrates for a possible antagonistic effect toward the compounds described in this report, but as yet none have shown any evidence of this activity.
SUMMARY
The in vitro antibacterial effects of a series of benzene sulfonic acid derivatives are presented.
The compounds which have halogen groups substituted in the 3,4 or 3,5 positions on the anilide portion of the molecule are usually more effective.than the mono-halogenated compounds.
An acetyl group in the N4 position greatly diminishes the antibacterial effects of the parent compound.
The sulfanilylanilides and benzenesulfonanilides are unaffected by the presence of p-aminobenzoic acid.
